Hepion Pharmaceuticals, Inc.·4

May 20, 4:36 PM ET

JACOB GARY S 4

4 · Hepion Pharmaceuticals, Inc. · Filed May 20, 2021

Insider Transaction Report

Form 4
Period: 2021-05-18
JACOB GARY S
DirectorCEO and President
Transactions
  • Award

    Stock Options

    2021-05-18+250,000342,785 total
    Exercise: $1.70From: 2022-05-18Exp: 2031-05-18Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.

Documents

1 file
  • 4
    tm2117144d6_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT